REFERENCES

Alabdalla, M. A. 2005. Chemical characterization of counterfeit Captagon tablets seized in Jordan. Forensic Science International 152:185-188.

Barlow, R. 2012. A new counterfeit problem: Anti-malarial drugs. BU Today, July 26.

Barras, J., K. Althoefer, M. D. Rowe, I. J. Poplett, and J. A. S. Smith. 2012. The emerging field of medicines authentication by nuclear quadrupole resonance spectroscopy. Applied Magnetic Resonance 43(4):511-529.

Bate, R., and A. Mathur. 2011. Working paper: The impact of improved detection technology on drug quality: A case study of Lagos, Nigeria. Washington, DC: American Enterprise Institute.

Bate, R., R. Tren, K. Hess, L. Mooney, and K. Porter. 2009a. Pilot study comparing technologies to test for substandard drugs in field settings. African Journal of Pharmacy and Pharmacology 3(4):165-170.

Bate, R., R. Tren, L. Mooney, K. Hess, B. Mitra, B. Debroy, and A. Attaran. 2009b. Pilot study of essential drug quality in two major cities in India. PLoS ONE 4(6):e6003.

Brown, T., H. E. LeMay, B. Bursten, C. Murphy, and P. Woodward. 2011. Chemistry: The central science. 12th ed. Boston, MA: Prentice Hall.

Deisingh, A. K. 2005. Pharmaceutical counterfeiting. Analyst 130(3):271-279.

Dowell, F. E., E. B. Maghirang, F. M. Fernandez, P. N. Newton, and M. D. Green. 2008. Detecting counterfeit antimalarial tablets by near-infrared spectroscopy. Journal of Pharmaceutical and Biomedical Analysis 48:1011-1014.

EurekAlert. 2012. New technology represents next-generation tool for detecting substandard and counterfeit medicines. http://www.eurekalert.org/pub_releases/2012-07/up-ntr072612.php (accessed January 31, 2013).

Fernandez, F. M., M. D. Green, and P. N. Newton. 2008. Prevalence and detection of counterfeit pharmaceuticals: A mini review. Industrial and Engineering Chemistry Research 47:585-590.

Fernandez, F. M., D. Hostetler, K. Powell, H. Kaur, M. D. Green, D. C. Mildenhall, and P. N. Newton. 2011. Poor quality drugs: Grand challenges in high throughput detection, countrywide sampling, and forensics in developing countries. Analyst 136(15):3073-3082.

Filho, A. F. M., P. Blanco, and L. E. Ferreira. 2010. Pharmaceutical products traceability system pilot project in Brazil. 2010/2011 GS1 Healthcare Reference Book. http://www.gs1.org/docs/healthcare/case_studies/Case_study_Brazil_pharma_traceability.pdf (accessed March 7, 2013).

Gaffney, A. 2012. New portable anti-counterfeiting technology promises “paradigm shift. http://www.raps.org/focus-online/news/news-article-view/article/2020/new-portable-anti-counterfeiting-technology-promises-paradigm-shift.aspx (accessed March 7, 2013).

Gamble, B. M., S. R. Gratz, J. J. Litzau, K. J. Mulligan, and R. A. Flurer. 2008. FDA forensic investigations using mass spectrometry. Paper presented at Conference on Small Molecule Science, San Jose, CA.

Gaudiano, M. C., E. Antoniella, P. Bertocchi, and L. Valvo. 2006. Development and validation of a reversed-phase lc method for analysing potentially counterfeit antimalarial medicines. Journal of Pharmaceutical and Biomedical Analysis 42:132-135.

Gottlieb, H. E., V. Kotlyar, and A. Nudelman. 1997. NMR chemical shifts of common laboratory solvents as trace impurities. Journal of Organic Chemistry 62:7512-7515.

GPHF (Global Pharma Health Fund). 2012a. GPHF-Minilab®—fact sheet. http://www.gphf.org/web/en/minilab/factsheet.htm (accessed July 30, 2012).

———. 2012b. The GPHF-Minilab®—focusing on prevalent medicines against infectious diseases. http://www.gphf.org/web/en/minilab/wirkstoffe.htm (accessed November 5, 2012).



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement